Phase II trial of everolimus monotherapy in the palliative treatment of patients with metastatic transitional cell carcinoma (TCC) after failure of platinum-based therapy: Activity and biomarkers. A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results